# IVF Additional Clinical Enhancements

**Status:** All 6 core phases complete. Additional features for clinical excellence.

---

## **PHASE 7: Clinical Decision Support & Safety**

### 7.1 OHSS Risk Calculator (Venice 2016 Criteria)
**Real-time scoring system with mitigation strategies**

```
OHSS RISK ASSESSMENT (Venice 2016)
â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”

RISK FACTORS (Points):
â–¡ Age <35 years: +2 points âœ“
â–¡ BMI <18 or PCOS: +1 point âœ“ (PCOS)
â–¡ AFC >15: +1 point âœ“ (AFC: 22)
â–¡ E2 >3000 on trigger: +2 points âœ“ (E2: 3200)
â–¡ >20 follicles >11mm: +1 point âœ“ (23 follicles)
â–¡ >15 oocytes retrieved: +1 point â³ (pending)
â–¡ Pregnancy achieved: +2 points â³ (pending)

CURRENT SCORE: 7/10 before retrieval

RISK STRATIFICATION:
â€¢ 0-3: Low risk (routine monitoring)
â€¢ 4-6: Moderate risk (enhanced monitoring)
â€¢ 7-9: High risk (prevention protocol)
â€¢ 10: Critical risk (aggressive prevention)

CURRENT STATUS: ğŸ”´ HIGH RISK

PREVENTION PROTOCOL ACTIVATED:
âœ… MANDATORY ACTIONS:
1. GnRH agonist trigger (Lupron 80 units) - NO hCG
2. Freeze all embryos - NO fresh transfer
3. Cabergoline 0.5mg PO daily Ã— 8 days starting retrieval day
4. Metformin 500mg TID (continue if PCOS)

âœ… MONITORING SCHEDULE:
â€¢ Day 3 post-retrieval: Vitals, symptoms, abdominal exam
â€¢ Day 5 post-retrieval: Labs (Hct, WBC, LFTs), U/S if symptomatic
â€¢ Day 7 post-retrieval: Final check, symptoms assessment

âš ï¸ RED FLAGS - Call immediately if:
â€¢ Weight gain >2 kg in 24h
â€¢ Urine output <500 mL/day
â€¢ Severe abdominal bloating/distension
â€¢ Nausea, vomiting, inability to keep fluids down
â€¢ Shortness of breath, chest pain
â€¢ Severe abdominal pain

DISCHARGE INSTRUCTIONS AUTO-GENERATED
PATIENT ALERT SMS SCHEDULED
```

**Implementation:**
- Real-time score calculation during monitoring
- Auto-triggers prevention protocols
- Patient SMS alerts for monitoring
- Emergency hotline integration

---

### 7.2 Trigger Decision Support System
**AI-powered trigger timing recommendation**

```
TRIGGER READINESS ASSESSMENT
â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”

Stimulation Day: 11
Last Monitoring: Today 8:00 AM

FOLLICLE COHORT ANALYSIS:
Lead Follicles (â‰¥18mm): 6 follicles âœ“
â”œâ”€ Right: 19, 19, 18 mm
â””â”€ Left: 20, 19, 18 mm

Supporting Cohort (16-17mm): 5 follicles âœ“
â”œâ”€ Right: 17, 16 mm
â””â”€ Left: 17, 17, 16 mm

Small Follicles (<14mm): 3 follicles
â”œâ”€ Will likely not mature in time
â””â”€ Acceptable loss

HORMONAL READINESS:
E2: 2400 pg/mL âœ“ (Target: 150-250 per lead follicle)
â”œâ”€ Per follicle: 218 pg/mL âœ“ (optimal)
â””â”€ Rise pattern: Steady, appropriate âœ“

LH: 2.1 mIU/mL âœ“ (No spontaneous surge)
P4: 0.8 ng/mL âœ“ (Not elevated)

ENDOMETRIAL STATUS:
Thickness: 10mm âœ“ (Target: â‰¥8mm)
Pattern: Trilaminar âœ“ (Optimal for implantation)

â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”
RECOMMENDATION: âœ… READY TO TRIGGER TONIGHT

Trigger Medication: GnRH agonist (Lupron 80 units)
â”œâ”€ Rationale: OHSS risk score 7/10 (high)
â””â”€ Alternative: hCG 10,000 IU if low OHSS risk

Trigger Time: Tonight 10:00 PM
Retrieval Scheduled: Dec 23, 9:00 AM (36 hours post-trigger)

EXPECTED YIELD PREDICTION:
Mature Oocytes (M2): 10-12 (based on 16-17mm+ follicles)
Confidence: High (cohort well-synchronized)

NEXT STEPS:
1. Confirm trigger medication with patient (SMS sent)
2. Schedule retrieval room (booked automatically)
3. Start OHSS prevention protocol
4. Patient education: trigger injection video sent
â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”

CONFIDENCE SCORE: 95% â­â­â­â­â­
```

**Features:**
- Cohort synchronization analysis
- Yield prediction algorithm
- Automatic scheduling integration
- Patient SMS notifications
- Video education delivery

---

### 7.3 Medication Tracking & Compliance
**Detailed daily medication log with adherence monitoring**

```
MEDICATION ADMINISTRATION LOG
â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”

Cycle Day 7 | Stim Day 7 | Dec 19, 2025

MORNING MEDICATIONS (8:00 AM):
âœ… Gonal-F 225 IU SC (abdomen right)
   â””â”€ Administered: 8:15 AM by patient
   â””â”€ Lot #: GF-2024-1234 | Exp: 2026-03
   â””â”€ Photo verification: âœ“ uploaded

EVENING MEDICATIONS (8:00 PM):
â³ Cetrotide 0.25mg SC (abdomen left)
   â””â”€ Due: 8:00 PM tonight
   â””â”€ SMS reminder sent: 7:30 PM
   â””â”€ Push notification: 7:55 PM

MEDICATION INVENTORY:
Gonal-F 900 IU pen: 2 doses remaining
â”œâ”€ Reorder alert: Will need refill by Day 9
â””â”€ Prescription sent to pharmacy âœ“

Cetrotide 0.25mg: 5 doses remaining (sufficient)

ADHERENCE SCORE: 98% (Excellent)
â”œâ”€ On-time doses: 12/13 (92%)
â”œâ”€ Missed doses: 0
â””â”€ Late doses (>30 min): 1

DOSE HISTORY (Last 7 days):
Day 1: Gonal-F 225 IU âœ“
Day 2: Gonal-F 225 IU âœ“
Day 3: Gonal-F 225 IU âœ“
Day 4: Gonal-F 225 IU âœ“
Day 5: Gonal-F 225 IU + Cetrotide 0.25mg âœ“
Day 6: Gonal-F 225 IU + Cetrotide 0.25mg âœ“ (late 45min)
Day 7: Gonal-F 225 IU âœ“ + Cetrotide 0.25mg â³

TOTAL COST TRACKING:
Gonal-F: $3,600 (16 doses @ $225/dose)
Cetrotide: $875 (7 doses @ $125/dose)
Trigger (Lupron): $150 (1 dose)
Total Medications: $4,625

Insurance Coverage: $2,000 (43%)
Out-of-Pocket: $2,625
```

**Features:**
- Photo verification of injections
- SMS/push reminders
- Adherence tracking with scoring
- Automatic refill alerts
- Cost transparency
- Insurance integration

---

### 7.4 Clinical Alerts Dashboard
**Real-time safety monitoring system**

```
CLINICAL ALERTS DASHBOARD
â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”

ğŸ”´ CRITICAL ALERTS (Immediate Action Required): 1

Alert #A-2025-0034 | OHSS Risk - High
Patient: Sarah Johnson | MRN: 12345
â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”
OHSS Risk Score: 7/10 (HIGH)
Trigger Today: Yes (scheduled 10:00 PM)
Action Required: Switch to GnRH agonist trigger
Status: â³ Pending MD review
Assigned To: Dr. Smith
Due: Within 2 hours
â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”

ğŸŸ¡ WARNING ALERTS (Review Today): 3

Alert #A-2025-0035 | Low E2 Rise
Patient: Mary Chen | MRN: 67890
â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”
E2 Day 5: 120 pg/mL â†’ Day 7: 180 pg/mL
Rise: 30% in 48h (Expected: 50-100%)
Follicle Count: 8
Action: Consider increasing FSH dose
Status: â³ Pending MD review
â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”

Alert #A-2025-0036 | Premature LH Surge
Patient: Lisa Brown | MRN: 11223
â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”
LH: 12.5 mIU/mL (was 3.2 yesterday)
Stim Day: 8
Lead Follicle: 16mm (not ready)
Action: Emergency trigger or cycle cancellation
Status: ğŸ”´ MD contacted - awaiting decision
â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”

Alert #A-2025-0037 | Medication Adherence
Patient: Anna Davis | MRN: 33445
â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”
Missed Dose: Cetrotide (yesterday evening)
Risk: Premature ovulation
Action: Additional monitoring U/S + LH check
Status: â³ Scheduled for today 2:00 PM
â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”

ğŸŸ¢ ROUTINE MONITORING (No Action): 12

âœ“ 12 patients with normal progression
âœ“ All within expected parameters
âœ“ Next monitoring as scheduled
```

**Alert Categories:**
- OHSS risk elevation
- Poor ovarian response
- Premature LH surge
- Medication non-compliance
- Lab result abnormalities
- Cycle cancellation criteria
- Embryo development issues
- Post-retrieval complications

---

## **PHASE 8: Patient Engagement & Education**

### 8.1 Interactive Patient Timeline
**Visual journey from consultation to pregnancy**

```
IVF JOURNEY TIMELINE - Sarah Johnson
â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”

Nov 15  Dec 1   Dec 15  Dec 23  Jan 10  Jan 24  Feb 1
  â”‚       â”‚       â”‚       â”‚       â”‚       â”‚       â”‚
  â”œâ”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”¤
  1ï¸âƒ£     2ï¸âƒ£     3ï¸âƒ£     4ï¸âƒ£     5ï¸âƒ£     6ï¸âƒ£     7ï¸âƒ£

1ï¸âƒ£ CONSULTATION & TESTING (Nov 15)
   âœ… Initial consultation
   âœ… Baseline labs (AMH, FSH, AFC)
   âœ… Semen analysis
   âœ… Financial counseling
   âœ… Consent forms signed
   Duration: 1 day | Status: Complete

2ï¸âƒ£ CYCLE PREPARATION (Dec 1)
   âœ… Birth control pills (14 days)
   âœ… Baseline ultrasound
   âœ… Medication training
   Duration: 14 days | Status: Complete

3ï¸âƒ£ STIMULATION PHASE (Dec 15-23)
   ğŸ”„ Daily injections (Gonal-F, Cetrotide)
   ğŸ”„ Monitoring visits (Day 1, 3, 5, 7, 9, 11)
   â³ Trigger injection (Tonight Dec 21)
   Duration: 9 days | Status: In Progress (Day 7)
   Next Visit: Dec 22 (8:00 AM)

4ï¸âƒ£ EGG RETRIEVAL (Dec 23)
   â³ Procedure scheduled: 9:00 AM
   â³ Anesthesia: IV sedation
   â³ Recovery: 2-3 hours
   Expected: 10-14 eggs
   Duration: 1 day | Status: Scheduled

5ï¸âƒ£ FERTILIZATION & EMBRYOLOGY (Dec 23-29)
   â³ ICSI fertilization: Same day
   â³ Fertilization check: Dec 24
   â³ Daily embryo updates: Dec 25-29
   â³ Freeze embryos: Day 5-6
   Duration: 6 days | Status: Pending

6ï¸âƒ£ FET CYCLE PREP (Jan 1-24)
   â³ Estrogen priming: 14 days
   â³ Endometrial check: Jan 15
   â³ Progesterone phase: 6 days
   Duration: 24 days | Status: Not Started

7ï¸âƒ£ EMBRYO TRANSFER (Jan 24)
   â³ Transfer procedure
   â³ Beta hCG test: Feb 3 (10dp5dt)
   Duration: 1 day | Status: Not Started

â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”
OVERALL PROGRESS: â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘ 45%

MILESTONES ACHIEVED: 8/15
DAYS IN TREATMENT: 36 days
ESTIMATED COMPLETION: Feb 3, 2026 (43 days total)
```

**Features:**
- Interactive drag/zoom timeline
- Daily notifications
- Educational videos per phase
- Photo diary upload
- Emotional support check-ins
- Financial milestone tracking

---

### 8.2 Patient Education Hub
**Integrated educational content delivery**

```
EDUCATIONAL CONTENT - Triggered by Phase

CURRENT PHASE: Stimulation Monitoring
â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”

ğŸ“š RECOMMENDED LEARNING (Auto-assigned):

âœ… COMPLETED:
â€¢ How to Mix and Inject Gonal-F (Video: 5 min)
â€¢ Understanding Follicle Growth (Article: 8 min)
â€¢ What is Cetrotide and Why You Need It (Video: 4 min)

ğŸ”„ IN PROGRESS:
â€¢ Trigger Shot Instructions (Video: 6 min)
  â””â”€ Progress: 60% | Watch by: Tonight
  â””â”€ Quiz: 3/5 questions correct (retake available)

â³ UPCOMING (Unlock in 2 days):
â€¢ What to Expect on Retrieval Day (Video: 10 min)
â€¢ Post-Retrieval Care Instructions (Article: 5 min)
â€¢ Understanding Embryo Grading (Video: 8 min)

LEARNING SCORE: 85% (Very Good)
Total Time Invested: 1.2 hours

â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”
EDUCATIONAL LIBRARY (Browse All):

CATEGORIES:
ğŸ“– IVF Basics (12 articles, 8 videos)
ğŸ’‰ Medications & Injections (15 videos)
ğŸ”¬ Laboratory Process (6 videos, 4 articles)
ğŸ¤° Pregnancy & Beyond (10 articles)
ğŸ’° Financial Planning (5 articles, 2 calculators)
ğŸ˜Š Emotional Support (8 articles, 4 videos, 1 support group)

POPULAR CONTENT THIS WEEK:
1. Managing OHSS Symptoms (Video: 7 min) - 234 views
2. Embryo Grading Explained (Article: 6 min) - 189 views
3. Trigger Shot Tutorial (Video: 6 min) - 156 views
```

**Content Types:**
- Animated videos (2-10 min)
- Interactive quizzes
- Infographics
- Step-by-step photo guides
- FAQ database
- Peer support forum
- Live Q&A sessions

---

## **PHASE 9: Quality Assurance & Clinic Metrics**

### 9.1 Clinic Dashboard
**Performance metrics for continuous improvement**

```
CLINIC PERFORMANCE DASHBOARD
â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”
Period: Q4 2025 (Oct-Dec)

KEY PERFORMANCE INDICATORS:

CLINICAL PREGNANCY RATE:
Overall: 58.2% â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–‘â–‘â–‘â–‘â–‘â–‘ (Target: 55%)
â”œâ”€ Fresh transfers: 54.1%
â”œâ”€ FET (frozen): 61.3% â¬†ï¸ +3.2% vs Q3
â””â”€ By age group:
    â€¢ <35 years: 67.4% âœ…
    â€¢ 35-37 years: 58.9% âœ…
    â€¢ 38-40 years: 42.3% âœ…
    â€¢ >40 years: 28.1% âš ï¸ Below SART average

LIVE BIRTH RATE PER RETRIEVAL:
47.3% â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–‘â–‘â–‘â–‘â–‘â–‘ (Target: 45%)
Trend: â¬†ï¸ +2.1% vs Q3 2025

OOCYTE MATURITY RATE:
82.7% â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–‘â–‘ (Target: 75-85%)
â””â”€ Consistent performance âœ…

FERTILIZATION RATE (ICSI):
78.4% â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–‘â–‘ (Target: 70-80%)

BLASTOCYST FORMATION RATE:
58.9% â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–‘â–‘â–‘â–‘â–‘â–‘ (Target: 50-60%)
â””â”€ Excellent lab performance â­

OHSS INCIDENCE:
2.1% â–ˆâ–ˆâ–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘ (Target: <3%)
â”œâ”€ Mild: 1.8%
â”œâ”€ Moderate: 0.3%
â””â”€ Severe: 0.0% âœ…

CYCLE CANCELLATION RATE:
8.7% â–ˆâ–ˆâ–ˆâ–ˆâ–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘ (Target: <10%)
Reasons:
â”œâ”€ Poor response: 4.2%
â”œâ”€ OHSS risk: 2.1%
â”œâ”€ Premature LH surge: 1.5%
â””â”€ Patient choice: 0.9%

â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”

BENCHMARKING VS SART NATIONAL AVERAGE:

Parameter              Clinic  SART    Variance
â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”
CPR (<35 years)        67.4%   62.1%   +5.3% â­
LBR per retrieval      47.3%   43.8%   +3.5% â­
OHSS rate              2.1%    3.2%    -1.1% âœ…
Cancellation rate      8.7%    9.3%    -0.6% âœ…

OVERALL RANKING: Top 15% of US clinics â­â­â­â­â­

â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”

AREAS FOR IMPROVEMENT:
ğŸ¯ Priority 1: Success rates in >40 age group
   Action: Review stimulation protocols, consider donor options

ğŸ¯ Priority 2: Reduce poor responder cancellations
   Action: Better baseline screening, protocol optimization

ğŸ¯ Priority 3: Improve patient education completion
   Current: 68% | Target: 85%
```

---

### 9.2 Embryologist Quality Metrics
**Lab performance tracking**

```
EMBRYOLOGY LAB SCORECARD
â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”
Month: December 2025

EMBRYOLOGIST PERFORMANCE:

Dr. Emily Chen, PhD (Senior Embryologist)
â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”
ICSI Procedures: 24 cases

Fertilization Rate: 82.1% â­â­â­â­â­
â”œâ”€ Target: 70-80%
â””â”€ Ranking: #1 in team

Blastocyst Rate: 61.3% â­â­â­â­â­
â”œâ”€ Target: 50-60%
â””â”€ Above target consistently

Vitrification Survival: 98.7% â­â­â­â­â­
â”œâ”€ Target: >95%
â””â”€ Zero losses this month

Thaw Survival: 97.3% â­â­â­â­â­
â”œâ”€ Target: >90%
â””â”€ Excellent technique

Case Load: 24 cases (optimal range)
Complication Rate: 0%
Patient Feedback Score: 4.9/5.0

QUARTERLY BONUS ELIGIBILITY: âœ… QUALIFIED

â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”

EQUIPMENT PERFORMANCE TRACKING:

Incubator #3 (MINC-2024-03):
â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”
Temperature Variance: Â±0.02Â°C âœ…
COâ‚‚ Stability: Â±0.1% âœ…
Oâ‚‚ Stability: Â±0.2% âœ…
Door Opening Events: 156 (within limit)
Alarm Events: 0 âœ…

Last Calibration: Dec 1, 2025
Next Due: Jan 1, 2026
Status: âœ… OPTIMAL

Microscope #2 (OLYMPUS-IX73-02):
Last Service: Nov 15, 2025
Next Due: Feb 15, 2026
Status: âœ… OPERATIONAL
```

---

## **PHASE 10: Advanced Features**

### 10.1 PGT-A Integration
**Genetic testing workflow**

```
PGT-A TESTING WORKFLOW
â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”

EMBRYO BIOPSY TRACKING:

Cycle: #2025-0042 | Patient: Sarah Johnson

EMBRYO INVENTORY (Day 5/6 Blastocysts):

Embryo #1 (4AA - Day 5):
â”œâ”€ Biopsy: Dec 28, 2:30 PM by Dr. Chen
â”œâ”€ Cells Retrieved: 5-8 cells âœ…
â”œâ”€ Sent to Lab: Natera (FedEx #123456789)
â”œâ”€ Status: In transit â†’ ETA Lab: Dec 29
â”œâ”€ Results Expected: Jan 5, 2026
â””â”€ Current Status: Vitrified, Tank A-Slot 47

Embryo #2 (4AB - Day 5):
â”œâ”€ Biopsy: Dec 28, 2:45 PM by Dr. Chen
â”œâ”€ Cells Retrieved: 5-8 cells âœ…
â”œâ”€ Sent to Lab: Natera (same shipment)
â”œâ”€ Results Expected: Jan 5, 2026
â””â”€ Current Status: Vitrified, Tank A-Slot 48

... (8 total embryos biopsied)

RESULTS TRACKING:

â³ PENDING (8 embryos): Results in 7 days
âœ… COMPLETED (0 embryos): â€”
âŒ FAILED (0 embryos): â€”

AUTO-NOTIFICATIONS:
â€¢ SMS when results received
â€¢ Email detailed report
â€¢ Genetic counseling scheduled automatically
```

---

### 10.2 Cryopreservation Management
**Embryo storage tracking system**

```
CRYOSTORAGE INVENTORY
â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”

Patient: Sarah Johnson | MRN: 12345
Account Status: âœ… Active | Fees: Paid through 2026

STORAGE DETAILS:

Tank A - Liquid Nitrogen Dewar #1
Location: Main Lab - Bay 3
Temperature: -196Â°C âœ…
Alarm Status: Normal âœ…
Last Fill: Dec 20, 2025
Next Fill: Dec 27, 2025

EMBRYO INVENTORY: 8 embryos

Slot A-47: Embryo #1 (4AA) - Day 5
â”œâ”€ Frozen: Dec 28, 2025
â”œâ”€ Method: Vitrification
â”œâ”€ PGT-A: Pending (results Jan 5)
â”œâ”€ Quality: Excellent
â””â”€ Available for transfer: After PGT-A results

Slot A-48: Embryo #2 (4AB) - Day 5
â”œâ”€ Frozen: Dec 28, 2025
â”œâ”€ Method: Vitrification
â”œâ”€ PGT-A: Pending
â”œâ”€ Quality: Excellent
â””â”€ Available for transfer: After PGT-A results

... (6 more embryos)

STORAGE FEES:
Annual Fee: $800/year ($67/month)
Paid Through: Dec 31, 2026
Auto-Renewal: âœ… Enabled
Payment Method: Visa **** 4242

INSURANCE:
Embryo Insurance: âœ… Active
Coverage: $50,000 per incident
Premium: $120/year (included in storage fee)

CONSENT STATUS:
Storage Duration: 10 years (through 2035)
Disposition if unpaid: Contact clinic
Partner consent: âœ… On file (both signatures)
```

---

## **Implementation Recommendations**

### Priority Tiers:

**TIER 1 (Critical - Implement Now):**
- OHSS Risk Calculator (Venice 2016)
- Clinical Alerts Dashboard
- Medication Tracking with SMS reminders

**TIER 2 (High Value - Next Sprint):**
- Trigger Decision Support
- Patient Timeline View
- Quality Metrics Dashboard

**TIER 3 (Enhanced Experience - Future):**
- Patient Education Hub
- PGT-A Integration
- Cryopreservation Management

---

## **Summary**

**Current Status:**
- âœ… All 6 core clinical phases complete
- âœ… Full IVF workflow from baseline â†’ outcome
- âœ… Interactive analytics with Recharts
- âœ… 15+ React components, ~6,000 lines of code

**Additional Features Proposed:**
- Phase 7: Clinical Decision Support (OHSS, triggers, alerts)
- Phase 8: Patient Engagement (timeline, education)
- Phase 9: Quality Assurance (clinic metrics, benchmarking)
- Phase 10: Advanced Features (PGT-A, cryopreservation)

**Next Steps:**
Choose which features to implement based on:
1. Clinical safety priorities (OHSS calculator, alerts)
2. Patient experience improvements (timeline, education)
3. Operational efficiency (quality metrics, benchmarking)
4. Advanced workflows (PGT-A, storage management)
